A Netflix executive says he was fired after returning from a company retreat where he disclosed past use of medically prescribed ketamine, describing the moment as part of a “trust exercise.” According to reports, the executive earns about $1.1 million per year and was dismissed after he revealed—during an event presented as trust-building—that he had taken ketamine that was prescribed for medical reasons. One outlet reports that the executive was later fired following the disclosure, framing the retreat confession as a reason for his termination. Another outlet similarly describes the executive telling colleagues at the retreat about his prior ketamine use, and states that he is dismissed after his return. The accounts agree on the core timeline: disclosure at the retreat, subsequent firing, and the asserted medical nature of the ketamine. However, they do not provide details on Netflix’s internal rationale beyond tying the termination to the disclosure, nor do they include information about the executive’s role, the scope of the disclosure, or any company statement. The reports focus on the executive’s claims about why he was fired and the circumstances of the retreat discussion.